Investigator Site 11-183 — Opelousas, Louisiana

Investigator Site 11-183 is a clinical research site located in Opelousas, Louisiana, United States 70570.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigator Site 11-183 has participated in 1 clinical trials.

Therapeutic areas: Hyperkalemia.

Sponsors: Vifor Pharma, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Opelousas

Browse all research sites in Louisiana · View every site in Opelousas

• Opelousas General Hospital
• Opelousas General Hospital Wound Center
• Novartis Investigative Site
• Research Site
• CV Ins of the South
• Cardiovascular Institute of the South
• Novartis Investigator Site
• FMC Opelousas
• Acadiana Medicine Clinic
• Forest Investigative Site 1812
• Opelousas General
• Furiex Research Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator Site 11-183?

Investigator Site 11-183 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator Site 11-183 conducted?

Investigator Site 11-183 has 1 clinical trials on record. Their work covers Hyperkalemia.

Is Investigator Site 11-183 accredited by Crixeo Clinical Trials?

Investigator Site 11-183 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator Site 11-183?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.